We present The Medicine Maker 2020 Power List, which celebrates the great minds involved in the development of all therapeutics, from small molecules to biopharmaceuticals to advanced medicines. The list includes 60 inspirational professionals. Meanwhile in Upfront, researchers use silver nanoparticles to battle brain-eating amoeba, and a new drug to heal broken bones more quickly. In NextGen, we find out why plants could help accelerate the manufacture of a COVID-19 vaccine, and how lessons learned from decades of manufacturing mAbs are affecting processes for cell and gene therapies. Finally, we sit down with Stephen Tindal to discuss pharma forensics and mystery solving.
April 27, 2020
The Chinese market presents a major opportunity for pharma companies, but spending time and money on keeping track of its quickly shifting regulations – as recent changes in the excipients field have shown – is key to success
1 min read
April 24, 2020
Intel shows a rise in cell and gene therapy development in the US, with China not far behind
1 min read
April 23, 2020
What’s the fastest route to a COVID-19 vaccine?
1 min read
April 21, 2020
Glass is an indispensable primary packaging material for pharma, but alongside the many benefits of conventional glass are disadvantages, such as breakages, delamination, and glass particulates. It doesn’t have to be this way. Recent glass innovations can make a big difference.
1 min read
April 20, 2020
Lipid nanoparticles (LNPs) are typically seen as a niche approach to formulation, but with more complex molecules filling company pipelines, is it time for LNPs to finally shine? Rahul Keswani and Benjamin King are formulators at Exelead specializing in early stage LNP development. We asked for their take on the current market for LNPs.
1 min read
April 17, 2020
How plants could speed up vaccine manufacture to tackle the COVID-19 pandemic
1 min read
April 10, 2020
Clinical trial confusion, off-the-shelf cell therapy, 24-hour CAR-T, and more
1 min read
April 8, 2020
Sitting Down With... Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions, Swindon
1 min read
April 2, 2020
The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough?
1 min read
March 31, 2020
How can nanoparticles be used to prevent deaths caused by unicellular organisms?
1 min read
March 27, 2020
What lessons has the industry learned from the manufacture of monoclonal antibodies? And how can these help us face the challenges presented by viral vector production for cell and gene therapies?
1 min read
March 16, 2020
The world’s largest cell and gene CDMO, an exciting new TCR, and the global CAR-T picture… We examine what’s going on in advanced medicine
0 min read
